Combination drug invented by RedHill Biopharma will get rid of Helicobacter pylori infection in 90% of patients.
Oncology
Posted inClinical Trials, COVID-19, Infections, Oncology
Yeliva: New Drug for COVID-19
Oral opaganib will reduce the likelihood of death and accelerate recovery in hospitalized patients with COVID-19.
Posted inNew Drugs, Oncology, Regulatory
Tivdak: New Drug for Cervical Cancer
Tisotumab vedotin for therapy of previously treated recurrent or metastatic cervical cancer.
Posted inOncology, Research
Tecentriq Plus Avastin: Most Effective Treatment for Unresectable Hepatocellular Carcinoma
Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Kimmtrak: Groundbreaking Immuno-Oncological Treatment for Metastatic Uveal Melanoma
Tebentafusp is a pharmacological breakthrough in the fight against a deadly disease.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Welireg: New Treatment for Tumors in Von Hippel–Lindau Disease
Belzutifan by Merck & Co. is for the treatment of renal cell carcinoma, central nervous system hemangioblastomas, and pancreatic neuroendocrine tumors.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Fyarro: First Drug to Treat Perivascular Epithelioid Cell Tumor
PEComa is a very rare and aggressive subtype of soft tissue sarcoma.